Palomar Challenges Cresco Class Action Insurance Coverage


Cannabis business and insurance professionals inspect packaged products and inventory inside a warehouse while reviewing potential product liability, warning, and insurance coverage exposures.

Cannabis product liability and inventory coverage review


A new cannabis insurance coverage dispute is testing how commercial general liability and product liability policies respond to consumer lawsuits over marketing and product warnings. Palomar Excess & Surplus Insurance filed a federal lawsuit against Cresco Labs seeking a declaration that it has no duty to defend or indemnify the company in two pending consumer class actions. The dispute matters well beyond one operator because it shows how the allegations in a lawsuit, the damages being requested, and specific policy language can determine whether insurance responds.


Quick facts

• Palomar filed its coverage lawsuit on August 14, 2026 in federal court in Illinois

• The dispute involves separate commercial general liability and product liability policies issued to Cresco Labs LLC doing business as Sunnyside

• Cresco Labs Inc. is identified as an additional named insured under the policies

• The complaint says the insurance at issue has a $5 million per claim limit and that underlying plaintiffs have made a multimillion dollar demand

• The underlying Blackketter and Murray class actions were filed May 4

• Plaintiffs allege deceptive health and therapeutic marketing, inadequate warnings, consumer fraud, negligence, warranty claims, and other causes of action

• The Murray case also includes a federal RICO claim

• Palomar argues the plaintiffs primarily seek economic recovery rather than damages because of covered bodily injury or property damage

• Palomar also relies on several exclusions as additional reasons it says coverage should not apply

• No court ruling has established that Palomar owes or does not owe coverage

• The universal operator lesson is simple: buying liability insurance is only the first step because the wording of the claim and the wording of the policy determine how coverage is tested


If a product claim or consumer lawsuit could materially affect your operation, complete our quick Puro Risk intake form so you can organize policies, marketing records, product documents, claims procedures, and insurance information before a dispute becomes harder to manage.


Why this coverage dispute matters

The underlying consumer lawsuits accuse Cresco and other cannabis operators of making misleading health and therapeutic statements while allegedly failing to adequately warn consumers about potential risks.

The plaintiffs seek several forms of relief, including compensation for alleged economic losses, restitution, punitive damages, multiplied damages, penalties, and changes to future marketing and warnings.

Palomar argues those allegations do not fit the basic coverage grants in the policies.

That distinction matters because insurance coverage is not determined only by the size of a lawsuit or whether a company is named as a defendant. Courts look at the allegations, policy definitions, exclusions, damages requested, and other policy terms.


Why advertising injury does not mean every advertising lawsuit is covered

One of the most important lessons involves the phrase personal and advertising injury.

Palomar's general liability policy includes that coverage, but the complaint says it applies to specific offenses such as using another party's advertising idea, certain copyright or trade dress claims, defamation, and privacy violations.

Palomar argues the underlying allegations about misleading cannabis marketing do not fall within those listed offenses.

For operators, this is an important distinction. A lawsuit involving advertising does not necessarily qualify as an advertising injury under a liability policy.


Why product liability coverage is also being tested

Cresco also has a separate product liability policy, but Palomar argues that policy does not respond because the underlying plaintiffs are seeking economic losses rather than damages caused by bodily injury or property damage from a covered occurrence.

The insurer raises additional defenses involving expected or intended conduct, punitive damages, RICO allegations, knowing violations of state law, and other policy provisions.

These are Palomar's allegations and coverage positions. The court has not yet ruled that they are correct.

That unresolved status is important for operators reviewing the case.


Why defense costs deserve attention

A coverage dispute can create financial pressure long before an underlying class action reaches trial.

Palomar is asking the court to find that it has neither a duty to defend Cresco nor a duty to indemnify it for covered damages. If an insurer successfully avoids the defense obligation, legal expenses can become a major operating cost before liability is ever determined.

Operators should therefore treat claims reporting, policy review, record retention, and coordination with insurance professionals and coverage counsel as immediate tasks when significant litigation arrives.


If a claim could affect multiple insurance policies, complete the Puro Risk intake form to organize notices, policy periods, limits, exclusions, contracts, and supporting records before important deadlines are missed.


Conclusion

The Palomar and Cresco dispute is an early test of how cannabis liability insurance may respond to a new generation of consumer class actions focused on marketing, warnings, and alleged economic harm.

The court has not decided whether coverage exists.

The larger lesson is already clear. Operators should understand what their liability policies actually cover before a major claim arrives. Product liability, general liability, advertising injury, exclusions, damages definitions, and defense obligations can all produce different results depending on the allegations.

As consumer litigation develops, strong marketing controls and strong insurance review need to operate together.

Educational note: This article is for education only and is not legal, regulatory, claims, coverage, financial, product safety, marketing, or insurance advice. Actual coverage depends on the specific policy, endorsements, exclusions, allegations, facts, applicable law, and insurer determination.


What to do this week

• Review general liability and product liability coverage grants and exclusions

• Confirm which policies could respond to consumer product or marketing allegations

• Review health, therapeutic, safety, and product performance statements

• Confirm claims reporting procedures and notice requirements

• Organize product warnings, testing records, marketing approvals, and compliance files

• Map major allegations to policy language before assuming a claim is covered or excluded


FAQ

Why did Palomar sue Cresco Labs?

Palomar is seeking a court declaration that its policies do not require it to defend or indemnify Cresco in two consumer class actions.

What are the underlying lawsuits alleging?

Plaintiffs allege misleading health and therapeutic marketing, inadequate warnings, consumer protection violations, negligence, warranty claims, and other causes of action.

Does Cresco have product liability insurance?

Palomar's complaint identifies a separate commercial product liability policy as well as a commercial general liability policy.

Why does Palomar say the policies do not respond?

Among other arguments, Palomar says the plaintiffs do not seek damages because of covered bodily injury, property damage, or qualifying personal and advertising injury.

Has a court ruled that Cresco has no coverage?

No. Palomar has filed its coverage position with the court, but the dispute remains unresolved.


What is the biggest operator takeaway?

Insurance should be reviewed against real claim scenarios. Marketing allegations, product warnings, economic loss claims, exclusions, and defense obligations can create very different coverage outcomes.


Cannabis and insurance professionals examine product containers, packaging, and compliance documents inside a manufacturing facility, illustrating liability concerns involving marketing claims and product warnings.

Cannabis product warning and liability claims assessment


You might also like


SOURCES

MJBizDaily, Insurance Carrier Sues Major Cannabis MSO To Avoid Class Action Payout, August 19, 2026

https://mjbizdaily.com/news/insurance-carrier-sues-major-marijuana-mso-to-dodge-class-action-payout/617516/

MJBizDaily reports on Palomar's coverage lawsuit, the underlying class actions, the multimillion dollar demand, and the insurer's arguments regarding bodily injury, property damage, and personal and advertising injury.

Palomar Excess & Surplus Insurance Company v. Cresco Labs Inc., Complaint For Declaratory Judgment, filed August 14, 2026

https://storage.courtlistener.com/recap/gov.uscourts.ilnd.506145/gov.uscourts.ilnd.506145.1.0.pdf

The federal complaint identifies the policies, policy period, underlying lawsuits, requested damages, coverage arguments, and exclusions Palomar is asking the court to apply.

Insurance Journal, Big Tobacco Moment For Cannabis: What To Know About Murray v. Cresco, May 18, 2026

https://www.insurancejournal.com/news/national/2026/05/18/870102.htm

The analysis explains the underlying Murray litigation and why its marketing, consumer protection, warranty, negligence, and RICO allegations could create significant new insurance issues for cannabis operators.


Previous
Previous

New Mexico Cannabis Sales Stay Steady As Texas Border Towns Grow

Next
Next

Are AI Data Centers Coming For Cannabis Cultivation Real Estate?